CRC
Clinical trials for CRC explained in plain language.
Never miss a new study
Get alerted when new CRC trials appear
Sign up with your email to follow new studies for CRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis trial investigates whether a sensitive blood test (Signatera) can detect when it is safe to pause immunotherapy in people with advanced solid tumors like lung cancer, melanoma, and colorectal cancer. Participants are randomly assigned to either continuous standard immunother…
Matched conditions: CRC
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Virus cocktail takes on tough liver tumors
Disease control Not yet recruitingThis phase 2 trial tests whether injecting an oncolytic virus (H101) directly into liver tumors, along with radiation, chemotherapy, targeted therapy, and immunotherapy, can shrink or control colorectal cancer that has spread to the liver and cannot be removed by surgery. The stu…
Matched conditions: CRC
Phase: PHASE2 • Sponsor: Jun Huang • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Sniffing out cancer: new breath test could spot colon cancer before it spreads
Diagnosis Not yet recruitingThis study tests a new, non-invasive method to detect colorectal cancer and precancerous growths by analyzing odors from breath and intestinal gas. About 453 participants—including people with colorectal cancer, precancerous lesions, and healthy volunteers—will provide samples an…
Matched conditions: CRC
Sponsor: Beijing University of Chinese Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC